← Back to Search

Exercise for Prostate Cancer

N/A
Waitlist Available
Led By Kerri Winters-Stone, MD
Research Sponsored by OHSU Knight Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline up to 12 months
Awards & highlights

Study Summary

This trial is comparing tai ji quan, strength training, and stretching to see which is most effective in preventing falls and improving function in prostate cancer survivors receiving ADT.

Who is the study for?
Men with prostate cancer who are currently on androgen deprivation therapy (ADT) for at least 6 months or have been in the past, without other concurrent treatments. They must have had a fall in the last year or show certain signs of physical slowness. Participants need to be medically cleared for moderate exercise, able to attend most classes, fluent in English, not already doing similar exercises regularly, and free from cognitive issues that affect participation.Check my eligibility
What is being tested?
The GET FIT Prostate trial is testing three different types of exercise programs: tai chi focused on balance, strength training for muscle power, and stretching for mobility. Men will be randomly assigned to one program and followed over a period of 12 months to see which is best at preventing falls and improving function during/after ADT treatment.See study design
What are the potential side effects?
Potential side effects from participating may include typical risks associated with moderate intensity exercise such as muscle soreness or strain. However, all participants will be medically screened beforehand to minimize any serious health risks.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline up to 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline up to 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in number of falls
Secondary outcome measures
Change in functional balance
Change in functional mobility
Change in perceived physical function
+8 more

Side effects data

From 2010 Phase 2 trial • 167 Patients • NCT00112151
66%
Other noncardiovascular serious adverse events
13%
Other nonserious adverse events
11%
Persistently elevated PSA
4%
Total serious cardiovascular adverse events
4%
Persistently elevated HCT >= 54%
2%
Elevated AUA
100%
80%
60%
40%
20%
0%
Study treatment Arm
Placebo
Lower-range T
Higher-range T

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Tai Ji Quan TrainingExperimental Treatment1 Intervention
An integrated exercise routine consisting of 8 purposeful movement forms and a set of therapeutic movements. Participants attend a supervised, group-based tai ji quan program remotely where they perform an integrated exercise routine consisting of 8 purposeful movement forms and a set of therapeutic movements 3 times per week for 60 minutes per session.
Group II: Strength TrainingExperimental Treatment1 Intervention
Participants wear a weighted vest while performing exercises using functional movement patterns used in everyday activities (chair rises, 90° squats, side-to-side squats, toe raises, lunges (forward, lateral, backward, walking), multi-directional step ups). Participants attend supervised, group-based moderate-intensity strength training program remotely 3 times per week for 60 minutes per session.
Group III: Stretching ControlActive Control1 Intervention
Participants attend a supervised flexibility program where they will perform a series of whole body stretching exercises with a focus on developing and maintaining a healthy back. Participants attend a supervised, group-based supervised flexibility program remotely 3 times per week for 60 minutes per session.

Find a Location

Who is running the clinical trial?

Oregon Health and Science UniversityOTHER
973 Previous Clinical Trials
7,385,477 Total Patients Enrolled
20 Trials studying Prostate Cancer
7,031 Patients Enrolled for Prostate Cancer
OHSU Knight Cancer InstituteLead Sponsor
230 Previous Clinical Trials
2,090,391 Total Patients Enrolled
26 Trials studying Prostate Cancer
2,098 Patients Enrolled for Prostate Cancer
National Cancer Institute (NCI)NIH
13,660 Previous Clinical Trials
40,924,186 Total Patients Enrolled
560 Trials studying Prostate Cancer
506,760 Patients Enrolled for Prostate Cancer

Media Library

Strength training Clinical Trial Eligibility Overview. Trial Name: NCT03741335 — N/A
Prostate Cancer Research Study Groups: Strength Training, Stretching Control, Tai Ji Quan Training
Prostate Cancer Clinical Trial 2023: Strength training Highlights & Side Effects. Trial Name: NCT03741335 — N/A
Strength training 2023 Treatment Timeline for Medical Study. Trial Name: NCT03741335 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who is eligible to be included in this research endeavor?

"This research is searching for 335 people with a history of prostate cancer between 18 and 100 years old. To be included, the following must apply: The patient has completed any prior surgeries, radiation or chemotherapy at least 6 weeks before enrolment and not currently receiving adjuvant therapy other than ADT; Experienced 1 fall in the last year or slow Timed Up and Go (TUG) time (>= 12.0 seconds) OR slow chair stand time (>= 10.0 seconds); Currently on Androgen Deprivation Therapy (ADT) for >= 6 months OR had an extended course within the past decade."

Answered by AI

Is this experiment open to recruiting participants at present?

"According to clinicaltrials.gov, this research project is no longer enrolling participants and was last updated on November 21st 2022. Despite this trial's inactivity, there are 1,321 other medical studies actively seeking volunteers right now."

Answered by AI

Is the age cutoff for this trial above 35?

"The eligibility criteria for this trial mandates that qualified participants must be between 18 and 100 years of age. There are 76 clinical trials available to those younger than 18, while 1,315 studies are open to people who surpass the age of 65."

Answered by AI
Recent research and studies
~54 spots leftby Apr 2025